Close Menu

NEW YORK (GenomeWeb News) – Transgenomic has licensed exclusive rights to Cold-PCR technology from the Dana Farber Cancer Institute, the firm said Thursday.

The Omaha, Neb.-based pharmacogenomics firm said that it has exclusive rights to commercialize the technology for combined use with Sanger sequencing as well as for mitochondrial DNA analysis. Financial and further terms of the license were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.